Clearlake Capital-Backed nThrive to Acquire PELITAS
February 8, 2022nThrive, Inc. (“nThrive”), a healthcare revenue cycle management (“RCM”) software-as-a-service (“SaaS”) platform provider backed by Clearlake Capital Group, L.P. (together with certain affiliates, “Clearlake”), today announced it has signed a definitive agreement to acquire PELITAS, a leading provider of healthcare patient access, digital patient intake, and front-end RCM software solutions. Financial terms of the transaction were not disclosed.
Clearlake Capital-Backed Mold-Rite Packaging Names Healthcare Manufacturing Veteran Jim Fitzgerald as CEO
February 3, 2022Mold-Rite Packaging (“MRP”, “Mold-Rite” or the “Company”), a provider of value-added packaging components, such as child-resistant closures, dispensing closures, and jars to a variety of end-markets with a focus on health & wellness segments, today announced that Jim Fitzgerald will join MRP as CEO and a member of the Board of Directors.
Clearlake Capital Completes Acquisition of Quest
February 2, 2022Clearlake Capital Group, L.P. (together with its affiliates “Clearlake”) today announced that it has completed its previously announced acquisition of Quest Software (“Quest” or the “Company”), a global cybersecurity, data intelligence, and IT operations management software provider, from Francisco Partners.
Clearlake Capital-backed Unifrax Renames to Alkegen
January 24, 2022Unifrax, a leading manufacturer of high performance specialty materials used in advanced applications, announced today that it has changed its name to Alkegen, to reflect the new company created following the acquisition of Lydall late last year, and will also move its corporate headquarters to Dallas, Texas
Iterative Scopes announces $150 million Series B to advance AI-driven precision medicine for gastroenterology
January 19, 2022Iterative Scopes, a pioneer in the development of precision-based gastrointestinal (GI) disease technologies and software, announced today that it has raised $150 million in Series B financing to accelerate development of its core algorithmic innovations that are designed to transform gastroenterology care for patients.
Clearlake & TA Associates-backed Precisely signs a definitive agreement to acquire PlaceIQ
January 19, 2022Precisely, a global leader in data integrity software, today announced it has signed a definitive agreement to acquire PlaceIQ, a leading data and technology provider that powers marketing and business decisions with location-based consumer insights.
Digicert acquires IoT cybersecurity provider Mocana
January 13, 2022DigiCert, Inc., a leading provider of TLS/SSL, IoT and other PKI solutions, backed by Clearlake Capital Group. L.P. (“Clearlake”), Crosspoint Capital, and TA Associates, today announced that it has acquired Internet of Things (IoT) cybersecurity provider Mocana.
Clearlake Capital-backed Team Technologies acquires iiMED, a nearshore specialty manufacturer of FDA class I & II consumable medical devices
January 12, 2022TEAM Technologies, Inc. (“TEAM” or the “Company”), a growth-oriented North American engineering solutions and specialty manufacturer serving healthcare end markets and backed by Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”), announced today that it has acquired iiMED Medical Solutions, L.L.C. (“iiMED”) from affiliates of ACON Investments, L.L.C. Financial terms were not disclosed.
Constant Contact agrees to acquire Vision6
January 11, 2022Constant Contact, a digital marketing platform trusted by millions of small businesses, today announced it has signed a definitive agreement to acquire Vision6
Clearlake Year-End Recap
January 10, 20222021 was our busiest year since inception. We celebrated our 15-year anniversary and reached new milestones across platform investments, add-on acquisitions, and capital raised. We closed the year out with 12 new platforms, 50+ add-ons, and 7 realizations.
